All articles by Ross Law

Amgen speaks out about bone density concerns with obesity drug

Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s…
AbbVie’s stock plummets over 12% after schizophrenia drug flops in Phase II trials

AbbVie’s stock price fell over 12% after emraclidine, an investigational anti-psychotic being evaluated for the treatment of schizophrenia, failed to…
Customer-centricity takes spotlight during clinical transformation

Alcon decided to take a platform-based approach to support its clinical transformation efforts when parent company Novartis decided to spin…
Ondine accelerates pivotal antimicrobial trial after $11m financing

Ondine Biomedical will initiate a Phase III trial of its light-activated antimicrobial technology to reduce healthcare-associated infections (HAIs) early after…
Alloplex’s cancer immunotherapy shows promise in Phase I trial

Alloplex Biotherapeutics’ autologous SUPLEXA cell immunotherapy for cancer has demonstrated promise in a first-in-human study. In the Phase I trial,…

First participants dosed in trial of long-acting malaria preventative

Medicines for Malaria Venture (MMV) and Quotient Sciences have dosed the first participants in a trial of MMV371, a long-acting…
NIH launches precision medicine trial for myeloid cancers

The US National Institutes of Health (NIH) has launched a precision medicine trial that aims to match patients with myeloid…
Kezar Life Sciences discontinues lupus nephritis programme after fatalities

Clinical stage biopharma company Kezar Life Sciences is discontinuing its LN clinical programme following the death of four patients. In…
NovoCure scoops FDA approval on wearable for metastatic cancer treatment

NovoCure’s Optune Lua, a wearable indicated for use alongside PD-1/PD-L1 inhibitors (immunotherapy) or docetaxel in adult patients with metastatic non-small…
MHRA expects new UK clinical trial regulation implementation by January 2026

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) expects the new UK clinical trial regulation to be implemented by…